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Cellular homeostasis is regulated by signals through
multiple molecular networks that include protein
phosphorylation and metabolites. However, where
andwhen the signal flows through a network and reg-
ulates homeostasis has not been explored. We have
developed a reconstruction method for the signal
flow based on time-course phosphoproteome and
metabolome data, using multiple databases, and
have applied it to acute action of insulin, an important
hormone formetabolic homeostasis. An insulin signal
flows through a network, through signaling pathways
that involve 13 protein kinases, 26 phosphorylated
metabolic enzymes, and 35 allosteric effectors, re-
sulting in quantitative changes in 44 metabolites.
Analysis of the network reveals that insulin induces
phosphorylation and activation of liver-type phos-
phofructokinase 1, thereby controlling a key reaction
in glycolysis. We thus provide a versatile method of
reconstruction of signal flow through the network
using phosphoproteome and metabolome data.
INTRODUCTION
Cellular homeostasis is dynamically regulated by signals that are
transmitted in global multiple molecular (‘‘trans-omic’’) networks
that include proteins and their phosphorylation, mRNAs, and
metabolites (Brazhnik et al., 2002; Buescher et al., 2012; Feist
et al., 2009; Gerosa and Sauer, 2011; Gu¨ell et al., 2009; Ishii
et al., 2007; Joyce and Palsson, 2006; Ku¨hner et al., 2009; Loca-
sale et al., 2011; Oliveira et al., 2012; Shyh-Chang et al., 2013;
Vander Heiden et al., 2010; Yus et al., 2009). To understandCelthe mechanism of cellular homeostasis, we introduce here the
concept of signal flow. Signal flow consists of static signal flow
and dynamic signal flow. Static signal flow is the route of the
signal in a trans-omic network. Dynamic signal flow is the traffic
of the signal, or the temporal changes in molecular concentra-
tions that are transmitted through the route. Thus, traffic and
routes illustrate when andwhere signals flow in a network. Traffic
and routes characterize the dynamic nature of the homeostatic
system; however, signal flow has not been identified.
The analysis of signal flow requires simultaneous, global, mul-
tiple ‘‘omic’’ measurements under the same conditions. Quanti-
tative and global measurements in a single omic layer by use of
omic technology are now available (Bertone et al., 2004; Fiehn
et al., 2000; Fischer and Sauer, 2005; Ghaemmaghami et al.,
2003; Ishihama et al., 2005; Iwasaki et al., 2010; Nilsson et al.,
2010; Olsen et al., 2006; Soga et al., 2002). Measurements in a
single omic layer are often used in the screening of molecules
for specific cellular functions rather than in the identification of
trans-omic networks (Bartke et al., 2010; Lowery et al., 2007;
O’Connell et al., 2010). Connecting measurements of different
omic layers under different experimental conditions could allow
for the identification of possible trans-omic networks. However,
because molecular interactions between multiple omic layers
aremutually connected, signals that flow in a trans-omic network
cannot be reconstructed by integrating individual measurements
in single omic layers under different conditions; instead, these
signals should be reconstructed using simultaneous quantitative
measurements across trans-omic layers under the same condi-
tions (Wiley, 2011). A reconstruction method for the signal flow in
a trans-omic network based on simultaneously measured trans-
omic data has not yet been established.
Hormones regulate cellular homeostasis through selective
temporal control of multiple signaling pathways to exert specific
functions. Many hormones show distinct temporal patterns
in vivo (Brabant et al., 1992). For example, blood insulin, whichl Reports 8, 1171–1183, August 21, 2014 ª2014 The Authors 1171
Figure 1. Procedures of Reconstruction of
Signal Flow in the Trans-Omic Network
The procedures for the reconstruction of the signal
flow are based on phosphoproteome and metab-
olome data, which consist of seven successive
steps of retracing metabolites (the final output of
the system) to insulin (the input to the system). The
detailed procedures can be found in Supplemental
Experimental Procedures. See also Figure S2 and
Table S1.is a key hormone for metabolic homeostasis (Whiteman et al.,
2002), reportedly exhibits several specific temporal patterns,
including additional secretion that is transiently observed in
response to meals and basal secretion that is characterized by
persistently low circulating insulin concentrations (Lindsay
et al., 2003; Polonsky et al., 1988). We have previously shown
that insulin selectively changes the signal flow through signaling
pathways, depending on the temporal patterns (Kubota et al.,
2012; Noguchi et al., 2013). However, signal flow in a limited local
network was analyzed in previous studies (Kubota et al., 2012;
Noguchi et al., 2013), and the static signal flow and dynamic
signal flow of insulin in a whole trans-omic network have yet to
be uncovered.1172 Cell Reports 8, 1171–1183, August 21, 2014 ª2014 The AuthorsIn this study, we analyzed the signal
flow of acute insulin action in rat hepa-
toma FAO cells, which showed insulin-
dependent signaling activities similar to
those of primary hepatocytes (Kubota
et al., 2012). We developed the recon-
struction method of a static signal flow
in a trans-omic network using multiple
omic data and databases and identified
the static signal flow of acute insulin ac-
tion by retracing from the outputs of the
system (metabolites) to the input (insulin).
We analyzed the dynamic signal flow
of insulin-dependent glycolysis using
experiments with phospho-mimetic mu-
tants of liver-type phosphofructokinase
1 (PFKL), a key enzyme of glycolysis in
the liver, and kinetic modeling. We found
that insulin induces phosphorylation and
activation of PFKL and controls a key re-
action in glycolysis.
RESULTS
Procedures for Reconstruction
of Signal Flow in a Trans-Omic
Network
We attempted to identify signal flow in a
trans-omic network of acute insulin ac-
tion based on trans-omic data (Figure 1;
Experimental Procedures). We measured
time-course data from the metabolome,
phosphoproteome, and transcriptome ofacute insulin action (<60 min) under the same conditions in
FAO cells (Figure S1A), which consisted of 304 metabolites,
7,277 phosphorylated sites on 3,458 proteins, and 19,778 RNA
probes (Table S1; Figure S1B). Messenger RNAs of only two
related metabolic enzymes, including glucose-6-phosphatase
(G6Pase), changed within 60 min. G6Pase is known as a key
enzyme of gluconeogenesis and is rapidly responsive to insulin
(Figure S2A). However, the abundance of protein in G6Pase
did not vary within 60 min (Figure S2B). Therefore, we excluded
the contributions of protein and mRNA expression in acute insu-
lin action in this study. We postulated that acute insulin action in
metabolic control is primarily regulated by enzymatic activities
via protein phosphorylation and allosteric regulation rather than
by gene and protein expression. We analyze chronic insulin ac-
tion (>60 min) involving gene and protein expression in a sepa-
rate study.
We developed a reconstruction method of signal flow in a
trans-omic network of protein phosphorylation and allosteric-
regulation-dependent metabolism by acute insulin action. The
reconstruction method consists of the following seven proce-
dural steps (Figure 1; Experimental Procedures): (i) identification
of quantitatively changed metabolites (outputs of the system); (ii)
identification of ‘‘responsible metabolic enzymes’’ that poten-
tially regulate metabolite levels; (iii) identification of protein phos-
phorylation of responsible metabolic enzymes; (iv) identification
of protein-kinase-dependent insulin signaling; (v) identification
of the allosteric regulation; (vi) reconstruction of static signal
flow in a whole trans-omic network by integrating the results
from steps i through v; and (vii) kinetic modeling of dynamic
signal flow in the glycolytic pathway, which is one of the local
trans-omic networks.
Reconstruction of Static Signal Flow in a
Trans-Omic Network
Step i: Identification of Quantitatively Changed
Metabolites
We identified quantitatively changed metabolites and their
responsible metabolic enzymes and mapped them to the global
map provided in the Kyoto Encyclopedia of Genes andGenomes
(KEGG) PATHWAY database (Kanehisa et al., 2012), which in-
cludes a comprehensive metabolic pathway topology (Figures
2 and S3; Table S1). Hereafter, we refer to this map as the
KEGG global metabolism map. We succeeded in measuring
304 metabolites and observed that 44 metabolites were signifi-
cantly changed (27 increased and 17 decreased) in response
to insulin stimulation (Figures 2 and S1B; Table S1). Not all of
the measured metabolites and enzymes are shown in Figure 2A
because the KEGG global metabolism map does not include all
of the known metabolites. Eleven metabolites were mapped on
glycolysis, ten metabolites were mapped on the TCA cycle,
and 81 were mapped on proteogenic amino acid metabolism
(Figure 2; Table S1). In central carbon metabolism, there was a
decrease in the upstream metabolites of glycolysis, including
glucose 6-phosphate (G6P; Figure 2A, no. 8) and fructose
6-phosphate (F6P; Figure 2A, no. 6). In contrast, there was an
increase in the downstream metabolites of glycolysis such as
fructose 1,6-bisphosphate (F1,6BP; Figure 2A, no. 14), 3-phos-
pho-D-glycerate (3PG; Figure 2A, no. 12), 2-phospho-D-glycer-
ate (2PG; Figure 2A, no. 16), and phosphoenolpyruvate (PEP;
Figure 2A, no. 4). In the TCA cycle, five metabolites were
increased including citrate (Figure 2A, no. 11), 2-oxoglutarate
(Figure 2A, no. 2), succinyl-CoA (Figure 2A, no. 7), fumarate (Fig-
ure 2A, no. 9), and malate (Figure 2A, no. 17). In the glycogen
metabolism pathway, glycogen increased (Figure 2A, no. 22).
These observations imply that there is an insulin-dependent,
large-scalemigration of carbons from glycolysis to the TCA cycle
and glycogenesis in central carbon metabolism.
Several metabolites in adjacent locations in the metabolic
pathways showed positive correlations with each other over
time (Figure 2B). These metabolites are likely to compose a
‘‘rapid-equilibrium metabolite pool’’ in which the metabolitesCelare in rapid equilibrium and exhibit similar time courses (Cama-
cho et al., 2005; Palsson, 2011). We defined a group of metabo-
lite pairs that resided within two enzyme steps from one another
in the metabolic pathway and that had time courses with a cor-
relation of r R 0.8 (r is the Pearson correlation coefficient) and
composed a rapid-equilibrium metabolite pool. If a pair of me-
tabolites two enzyme steps away is connected only via hub me-
tabolites such as ATP, then the pair was excluded from the pool
to filter out trivial metabolite pairs. The hub metabolites were
determined according to previous studies of network topology
(Table S2) (Alves et al., 2002). We found six rapid-equilibrium
metabolite pools: three pools in glycolysis (Figure 2, P1, P2,
and P3); one large pool including the TCA cycle (Figure 2, P6);
one pool in nucleotide metabolism (Figure 2, P4); and one pool
involving acetylglucosamine phosphates (Figure 2, P5; Table
S2). The two glycolytic pools (P1 and P3) (Bennett et al., 2009;
Camacho et al., 2005; Palsson, 2011; Wittmann et al., 2005)
and part of the pool around the TCA cycle (P6) (Wittmann
et al., 2005) previously have been reported as rapid-equilibrium
metabolite pools indicating that our analysis successfully identi-
fied the knownmetabolic changes. The other pools (Figure 2, P2,
P4, and P5; Table S2) are novel. The correlation coefficients be-
tween the metabolite pairs in the rapid-equilibrium metabolic
pools were statistically significant (p < 0.001). Most of themetab-
olite pairs not in the rapid-equilibrium metabolic pools did not
exhibit statistical significance (p > 0.1) (Table S2).
Step ii: Identification of ResponsibleMetabolic Enzymes
Changes in the levels of a metabolite are caused by changes in
the reaction rates of the production (influx) or consumption
(efflux) of that metabolite. A reaction rate is determined by the
enzymatic activity, amount of enzyme, amount of substrate,
and product levels. Hereafter, we define the enzymes that
directly produce or consume at least one quantitatively changed
metabolite as ‘‘responsible metabolic enzymes.’’ In other words,
a changed metabolite is a substrate or a product of responsible
metabolic enzymes.We identified 198 responsible metabolic en-
zymes for 44 changed metabolites from the KEGG PATHWAY
database (Figure 2A, black lines; Figure S1B). Only 25 of the
44 changed metabolites and 132 of the 198 responsible meta-
bolic enzymes are exhibited in Figure 2A. Hereafter, the number
of enzymes is counted in terms of enzyme commission (EC)
numbers (IUBMB, 1999). Changes in the activities of responsible
metabolic enzymes can be regulated by phosphorylation and
allosteric regulation via metabolites.
Step iii: Identification of Protein Phosphorylation of
Responsible Metabolic Enzymes
We examined protein phosphorylation of responsible metabolic
enzymes, which can potentially change their enzymatic activities
(Figure 3A). From the phosphoproteomic data, 199 phospho-
peptides derived from 49 responsible metabolic enzymes were
identified (Figure S1B). Among these phosphopeptides of the
responsible metabolic enzymes, we selected quantitatively
changed phosphopeptides. A total of 106 phosphopeptides of
26 responsible metabolic enzymes were selected as the signifi-
cantly phosphorylated phosphopeptides (Figures 3A and S1B;
Table S3). These 26 phosphorylated responsible metabolic en-
zymes corresponded with 19 quantitatively changed metabolites
(Figure 3A). We found that 23 phosphorylated sites of thel Reports 8, 1171–1183, August 21, 2014 ª2014 The Authors 1173
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responsible metabolic enzymes had already been registered in
the PhosphoSitePlus (http://www.phosphosite.org) database
(Hornbeck et al., 2012) and that 48 phosphorylated sites of the
responsible metabolic enzymes were novel. One phosphoryla-
tion site could be covered by multiple phosphopeptides. Some
responsible metabolic enzymes with insulin-dependent phos-
phorylation, including ATP-citrate lyase (ACLY) at S455 (Berwick
et al., 2002), carbamoyl-phosphate synthetase 2 (CAD) at S1859
(Hsu et al., 2011), and 6-phosphofructo-2-kinase/fructose 2,6-bi-
sphosphatase (PFKFB3) at S461 (Atsumi et al., 2005) have
already been reported, indicating that our analysis successfully
identified the known protein phosphorylation of the responsible
metabolic enzymes. Given that phosphorylation of responsible
metabolic enzymes is considered to be relayed by the protein
phosphorylation-dependent signaling network of insulin, these
26 phosphorylated responsible metabolic enzymes are potential
primary targets of insulin signal flow in the metabolome layer.
Step iv: Identification of Protein-Kinase-Dependent
Insulin Signaling
Next, we attempted to identify the signal flow in the protein-ki-
nase-dependent insulin-signaling network that connects insulin
to the responsible metabolic enzymes. First, we identified poten-
tial upstream protein kinases for the phosphorylated responsible
metabolic enzymes through the amino acid sequences of the
phosphorylated peptides derived from the responsible meta-
bolic enzymes (Table S3). Hereafter, we denote these upstream
kinases as ‘‘responsible protein kinases’’ for responsible meta-
bolic enzymes. We selected the most probable kinases pre-
dicted by NetPhorest as the responsible protein kinases (see
Table S3 for distributions of scores [posterior probability] for
each phosphorylation site). NetPhorest is an analytical tool that
predicts responsible protein kinases by probabilistic models us-
ing the amino acid sequence of phosphopeptide (Miller et al.,
2008). We identified 13 responsible protein kinases of the phos-
phorylated responsible metabolic enzymes as a whole (Figures
3B and S1B; Table S3). Hereafter, we counted the numbers of
the responsible protein kinases using the kinase classifiers of
NetPhorest. These 13 responsible protein kinases include AKT,
glycogen synthase kinase-3b (GSK3b), and p70 ribosomal pro-
tein S6 kinase (p70S6K), which are key signaling molecules in
the insulin-signaling pathway. With the phosphorylated res-
ponsible metabolic enzymes in step iii, we connected the insu-
lin-signaling pathway map provided by the KEGG PATHWAY
database to the responsible protein kinases (Figure 3C). Here-
after, we refer to the insulin-signaling pathway map in Figure 3C
as the insulin-signaling pathway. Among the 13 responsible pro-Figure 2. Identification of Quantitatively Changed Metabolites and Res
(A) Quantitatively changed metabolites and responsible metabolic enzymes pro
black lines represent responsible metabolic enzymes. For the metabolites, the do
no changes in response to insulin, respectively. Numbers adjacent to the dots ar
together with corresponding metabolite names in Table S1. The numbers surro
respectively, in response to insulin stimuli. P1 through P6 indicate the locations
plemental Experimental Procedures).
(B) The time courses of metabolites in rapid-equilibrium metabolic pools (P1–P6
metabolite concentration is 1 nmol/1.73 107 cell. Insulin concentrations are as fol
between themetabolites represent that the metabolites are one enzyme step awa
metabolites correspond to Pearson correlation coefficients (red: rR 0.9; black:
See also Figure S3 and Table S2.
Celtein kinases, five kinases (AKT, GSK3b, p70S6K, PKA, and PKC;
Figure 3C) were connected to the insulin-signaling pathway and
eight kinases (AKT, CK2, CLK, GSK3, NEK1, PKA, PKC, and
p70S6K; Table S3) were phosphorylated (Figure S1B). There
were 71 phosphorylation sites on the 26 responsible metabolic
enzymes connected to the 13 responsible protein kinases (Table
S3; Figure S1B). The resulting insulin-signaling pathway included
the phosphorylation of signaling molecules, such as IRS, Raptor,
TSC1, and S6 (Cheng et al., 2010), the responsible protein ki-
nases, such as AKT, GSK3b, p70S6K, and ERK1/2 (Cheng
et al., 2010), and the phosphorylated responsible metabolic en-
zymes, such as ACLY (Berwick et al., 2002) and liver-type phos-
phofructokinase 1 (PFKL), which catalyze F6P into F1,6BP, a key
enzyme in glycolysis (Figure 3C). This result indicates that our
analysis successfully identified the known protein phosphoryla-
tion of the responsible metabolic enzymes and demonstrates
how insulin transmits its signal to the responsible protein ki-
nases and responsible metabolic enzymes through the signaling
pathways.
Step v: Identification of Allosteric Regulation
In addition to the protein phosphorylation-dependent changes in
the activities of the responsiblemetabolic enzymes, the activities
of the responsible metabolic enzymes are regulated by allosteric
effectors (activators and inhibitors) that are metabolites (Fig-
ure 4A). We searched the allosteric effectors of all the respon-
sible metabolic enzymes (198 enzymes) from the BRENDA
(http://www.brenda-enzymes.org/) database (see Experimental
Procedures) (Schomburg et al., 2013), which provides informa-
tion regarding allosteric effectors and their target enzymes
from a comprehensive literature search. We found that 35
quantitatively changed metabolites function as allosteric effec-
tors for the 94 responsible metabolic enzymes via 226 allo-
steric regulation (36 activation, 190 inhibition) (Figure 4B;
Figure S1B; Table S4). A metabolite can operate as an activator
for some enzymes and as an inhibitor for others. We also found
quantitative changes in 24 substrates for 74 responsible meta-
bolic enzymes and 25 products for 122 responsible metabolic
enzymes from the KEGG PATHWAY database (Figures 4C and
4D; Table S4).
Step vi: Reconstruction of theStatic Signal Flowof Acute
Insulin Action in a Trans-Omic Network
We integrated the results of steps i through v and reconstructed
the static signal flow of acute insulin action in a trans-omic
network (Figure 5; Movie S1). An insulin signal was first trans-
mitted through insulin receptors (IRs) to signaling pathways
including the 13 responsible protein kinases, such as AKT andponsible Metabolic Enzymes Corresponding to Steps i and ii
jected on the KEGG global metabolism map. Dots represent metabolites and
ts with red, blue, and green backgrounds represent an increase, decrease, and
e unique identifiers of quantitatively changed metabolite, which are presented
unded by red and blue indicate the metabolite was increased or decreased,
of six rapid-equilibrium metabolite pools (surrounded by dashed lines) (Sup-
). The means and SDs of three independent points are shown. The unit for the
lows: 0.01 nM (blue); 1 nM (green); and 100 nM (red). The bold and dashed lines
y and two enzyme steps away, respectively. The colors of the lines between the
0.8% r < 0.9).
l Reports 8, 1171–1183, August 21, 2014 ª2014 The Authors 1175
(legend on next page)
1176 Cell Reports 8, 1171–1183, August 21, 2014 ª2014 The Authors
p70S6K (Figure 5, top layer; Figure S1B). The responsible protein
kinases potentially transmit a signal to the 26 phosphorylated
responsible metabolic enzymes through 71 phosphorylation
sites (Figure 5, orange arrows from the top to the middle layer;
Figure S1B). A protein kinase can phosphorylate multiple meta-
bolic enzymes, and a metabolic enzyme can be phosphorylated
by multiple kinases. The 35 changed metabolites serve as allo-
steric effectors and feedback signals to the 94 responsiblemeta-
bolic enzymes through 36 activation and 190 inhibition (Figure 5,
red and blue arrows from the bottom to the middle layer; Fig-
ure S1B). The 198 responsible metabolic enzymes, including
26 phosphorylated and 94 allosterically regulated enzymes, led
to changes in the 44 metabolites (Figure 5, white arrows from
the middle to the bottom layer; Figure S1B). The integration of
steps i through v revealed the global landscape of the signal
flow of acute insulin action in a trans-omic network (Figure 5).
Reconstruction of Dynamic Signal Flow in a Trans-Omic
Network of Glycolytic Pathway
Step vii: Reconstruction of Dynamic Signal Flow in a
Glycolytic Pathway of a Local Trans-Omic Network
Wenext examined the dynamic signal flow of insulin and attemp-
ted to construct a kinetic model of the trans-omic networks
based on the time-course omic data. However, because there
were many unmeasured metabolites, we could not develop the
kinetic model of the whole trans-omic network. Instead, we
focused on a local trans-omic network of the glycolytic pathway
between F6P and F1,6BP because of three reasons: insulin
induced phosphorylation of PFKL, a key enzyme in glycolysis;
F6P together with upstream molecules decreased (Figure 2B,
P1), whereas F1,6BP together with downstream molecules
increased (Figure 2B, P2 and P3), and F6P and F1,6BP exhibited
a strong negative correlation (r = 0.552), indicating that insulin
facilitates conversion of F6P into F1,6BP, and all metabolites
surrounding F6P and F1,6BP were measured (Figure 6A), which
is necessary for development of a kinetic model. Because the
functional role of phosphorylation at S775 of PFKL remains un-
known, we first examined the effect of phosphorylation at S775
of PFKL on its kinase activity by making phospho-mimetic
(S775D or S775E) and nonphospho-mimetic (S775A) mutants
(Figure 6B). Both phospho-mimetic PFKL mutants (S775D orFigure 3. Identification of Protein-Kinase-Dependent Insulin Signaling
(A) Identification of protein phosphorylation of responsible metabolic enzymes (s
indicates all of the significantly changed phosphorylation sites of the enzyme exhib
of the significantly changed phosphorylation sites of the enzyme exhibited a de
significantly changed phosphorylation sites of the enzyme exhibited either an in
colored lines (e.g., E3) are unique identifiers for 26 phosphorylated responsible m
(B) The 13 identified responsible protein kinases of phosphorylated metabolic e
kinase tree (Miller et al., 2008). The detailed relationship between the responsible
S3. The colors indicate the phosphorylated protein kinases; red and green indicat
was not changed by insulin. Gray indicates not phosphorylated. *The kinases w
indicates that CDK and MAPK families belong to the CMGC superfamily.
(C) Identification of protein-kinase-dependent insulin signaling to responsible me
ovals represent the following phosphorylation states: red and green indicate the
unchanged by the insulin; andwhite indicates no phosphorylation. Five kinases ou
(AKT, GSK3b, p70S6K, PKA, and PKC). The names in the boxes are phosphoryla
and inhibition, respectively. Orange denotes phosphorylation and black denotes
See Table S3 for the abbreviations of the phosphorylated metabolic enzymes.
CelS775E) exhibited increased kinase activity compared with the
wild-type PFKL, whereas the nonphospho-mimetic mutant
(S775A) did not (Figure 6B), indicating that insulin phosphory-
lates and activates PFKL. PFKL activity is regulated positively
by fructose-2,6-bisphosphate (F2,6BP); it is regulated negatively
by citrate, PEP, isocitrate, 2-oxolgutarate and malate (Passon-
neau and Lowry, 1963) (Figure 6A). PFKL activity also has been
shown to be regulated by ATP, ADP, AMP, and othermetabolites
(Mor et al., 2011; Scho¨neberg et al., 2013); however, because
these metabolites were unchanged in response to insulin (Table
S1), they were not considered in this study. The reverse reaction,
conversion of F1,6BP to F6P, is catalyzed by a different enzyme,
fructose-1,6-bisphosphatase (FBPase), whose activity is regu-
lated negatively by F2,6BP (Rakus et al., 2000) and positively
by citrate (Nimmo and Tipton, 1975) (Figure 6A).
We examined which phosphorylation and allosteric regulation
selectively contributed to conversion between F6P and F1,6BP
using a kinetic model of dynamic signal flow of insulin in the
glycolytic pathway (Figure 6C; Supplemental Experimental Pro-
cedures). In our experiments, therewas a transient and sustained
increase of F1,6BP (Figure 6C, dots); however, in our simulations,
only sustained increase of F1,6BP was reproduced (Figure 6C,
lines). This suggests the existence of the unknown signal flow
responsible for the transient increase of F1,6BP. We examined
which phosphorylation and allosteric regulation selectively
contributed to sustained increase of F1,6BPby variable selection
in the kinetic model (Figure 6D; Supplemental Experimental
Procedures). We selected five variables as the minimum set gov-
erning the dynamic signal flow (Figures 6D andS4A). The five var-
iables included phosphorylation of PFKL at S775 and allosteric
regulation by F2,6BP, PEP, citrate, and malate (Figures 6D and
6E). We made a kinetic model with five variables. This model ap-
peared to be comparable with the original full model using eight
variables (Figures 6E and S4B), confirming that the five variables
we used are the dominant factors for dynamic signal flow be-
tween F6P and F1,6BP (Figure 6E). Given that PEP, citrate, and
malate are downstream of F1,6BP, these metabolites serves as
negative-feedback regulators for F1,6BP production (Figures
6E, dashed line; Figures S4C–S4E), consistent with previous ob-
servations (Nimmo and Tipton, 1975; Passonneau and Lowry,
1963; Rakus et al., 2000). Insulin positively regulates F1,6BPto Responsible Metabolic Enzymes Corresponding to Steps iii and iv
tep iii). Colored lines are phosphorylated responsible metabolic enzymes. Red
ited an increase (>1.5-fold) in response to the insulin stimulus. Blue indicates all
crease (<0.67-fold) in response to the insulin stimulus. Green indicates all the
crease or a decrease in response to the insulin stimulus. Numbers next to the
etabolic enzymes, which are presented in Table S3.
nzymes. Boxes represent superfamilies of each protein kinase based on the
protein kinases and phosphorylated metabolic enzymes can be found in Table
e the same information as described in (A). Black indicates the phosphorylation
ere included in the insulin-signaling pathway. A dashed box labeled CMGC
tabolic enzymes (step iv). An oval corresponds to a protein. The colors of the
same information described in (A) and (B); gray indicates phosphorylation was
t of the 13 responsible kinases were connected to the insulin-signaling pathway
ted metabolic enzymes. An arrow and a bar-headed arrow indicate activation
other molecular interactions.
l Reports 8, 1171–1183, August 21, 2014 ª2014 The Authors 1177
Figure 4. Identification of Allosteric Regulation of Responsible
Metabolic Enzymes by Metabolites Corresponding to Step v
(A) The level of a metabolite (X) is determined by the balance between the
influxes and effluxes, i.e., the reaction rates of enzymes E1 and E2, respec-
tively. S denotes the substrate of E1, and P is the product of E2. Here, allosteric
regulation includes the regulation of influxes and effluxes by the binding of
metabolites acting as allosteric effectors (activators and inhibitors) to the en-
zymes and by the levels of the substrates and products.
(B) The allosteric regulation of the responsible metabolic enzymes (E) by the
allosteric effectors. The row labels are the responsible metabolic enzymes (E),
and the column labels are the activators and inhibitors of the influxes and ef-
fluxes (Table S4). A black dot is provided at row i column j if a responsible
metabolic enzyme of row i is regulated by an allosteric effector of column j.
Such information for allosteric regulation was obtained using the BRENDA
database (Experimental Procedures).
(C and D) The substrates (S) and the products (P) of the responsible metabolic
enzymes (E), respectively. A black dot is provided at row i column j if a
metabolite of column j is a substrate or a product of a responsible metabolic
enzyme of row i.
See Table S4 for complete information for (B)–(D).
1178 Cell Reports 8, 1171–1183, August 21, 2014 ª2014 The Authorproduction by phosphorylation of PFKL at S775 and by
increasing F2,6BP (Figures S4F and S4G); the latter is a well-
known and conserved mechanism throughout eukaryotes
(Rider et al., 2004). Our data indicate an additional role for insulin:
phosphorylation-dependent regulation of glycolytic enzymes
including PFKL. Thus, these results demonstrate that insulin co-
ordinately regulates the dynamic flow in the glycolytic pathway
by insulin-dependent activation of PFKL via phosphorylation
and increase of F2,6BP and by the negative-feedback loop via
downstream allosteric regulators.
DISCUSSION
In this study, we reconstructed static signal flow of acute insulin
action in a whole trans-omic network using time-course trans-
omic data combined with multiple databases and analyzed the
dynamic signal flow of a local network of the glycolytic pathway
using kinetic modeling. We first identified the quantitatively
changed metabolites, which are the outputs of the system
(step i; Figure 2).Weconnected thequantitatively changedmetab-
olites and potential responsible metabolic enzymes by using the
KEGGglobalmetabolismmap (step ii; Figure2). Among thepoten-
tial responsible metabolic enzymes, we identified the phosphory-
lated responsible metabolic enzymes with phosphoproteomic
data (step iii; Figure 3A). We connected the phosphorylated
responsible metabolic enzymes and the responsible protein ki-
nases with the amino acid sequences of phosphopeptides using
the NetPhorest and further connected the responsible protein ki-
nases and insulin-signaling pathway (step iv; Figures 3B and 3C;
Table S3). Finally,weconnected the allosteric regulationofmetab-
olites to the responsible metabolic enzymes using the BRENDA
database (step v; Figures 4A and 4B). Thus, we reconstructed
the static signal flow of acute insulin action by retracing the signal
flow from the outputs of the system (metabolites) to the input (in-
sulin) (step vi; Figure 5). Moreover, we reconstructed the dynamic
signal flow in a local network of the glycolytic pathway using the
kinetic modeling with variable selection (step vii; Figure 6).
The reconstruction of dynamic signal flow allowed us to iden-
tify a regulation of insulin-dependent glycolysis. We experimen-
tally found that insulin increases phosphorylation at S775 of
PFKL, leading to an increase in its kinase activity. With the vari-
able selection of the kinetic model, we demonstrated that insulin
can coordinately regulate the dynamic flow between F6P and
F1,6BP by insulin-dependent activation of PFKL via phosphory-
lation and increase of F2,6BP, and by the negative-feedback
loop via downstream allosteric regulators. The regulation of
the glycolytic pathway by F2,6BP and regulation by the nega-
tive-feedback loop via downstream metabolites are well-known
and conserved mechanisms throughout eukaryotes (Bloxham
and Lardy, 1973; Rider et al., 2004). Moreover, the phosphoryla-
tion site of S775 is specific to PFKL (liver-type PFK), but not to
other isoforms of PFKs, such as PFKM (muscle-type PFK) or
PFKP (platelet-type PFK) (Simpson and Fothergill-Gilmore,
1991). Given that the liver is the main target organ of insulin
and that it is specialized for controlling systemic glucose homeo-
stasis, and given the ubiquitous controlling mechanisms by
F2,6BP and downstream metabolites, special regulation of
glycolysis by insulin may be needed for tight control of glucoses
Figure 5. A Global Landscape of the Static
Signal Flow of Acute Insulin Action in a
Trans-Omic Network by Integrating the Re-
sults from Steps i through v Corresponding
to Step vi
The insulin signal flows across three layers:
the insulin-signaling pathway (the top layer); the
metabolic enzymes (the middle layer); and the
metabolites (the bottom layer). Orange arrows
(from the top to the middle layer) indicate the
signal flow from the responsible protein kinases to
the responsible metabolic enzymes, white arrows
(from the middle to the bottom layer) indicate the
signal flow from the responsible metabolic en-
zymes to the metabolites, and the red and blue
arrows (from the bottom to the middle layer) indi-
cate the signal flow of the allosteric regulation (red,
activator; blue, inhibitor). A 3D video file and a
network structure file of the static signal flow are
provided. The 3D video of the static signal flow can
be seen in Movie S1.metabolism in the liver. Our result suggests that insulin-de-
pendent phosphorylation of PFKL at S775 is one such special
mechanism of glucose metabolism in the liver. Further study is
necessary to address the role of phosphorylation of PFKL at
S775 in glucose metabolism in the liver.
The reliability of the signal flow analysis depends on the quality
and quantity of the trans-omic data, the criteria for the selection
of the data, and the comprehensiveness and reliability of the in-
formation available in the databases. With respect to the quality
of the trans-omic data, the current metabolome and phospho-
proteome data did not fully encompass all of the metabolites
and phosphopeptides, mostly because of technical reasons,
such as the lack of standard samples for some metabolites
and the low sensitivity of detection of the phosphopeptides.
Regarding the quantity of the trans-omic data, the sample
numbers of the trans-omic data, especially phosphoproteomic
data, were limited because of the slow throughput speed.
This method relies on several selection criteria such as the fold
change for selecting the changed metabolites and phosphopep-
tides and a residual sum of squares for selecting essential vari-
ables by variable selection. Because other criteria might improve
the reliability of our analysis, other criteria should be tested in the
future. For comprehensiveness and reliability of the information
available in the databases, we used the KEGG PATHWAY data-
base for a global metabolic map and the insulin-signaling
pathway, the latter of which does not encompass all of the
signaling molecules. We used the NetPhorest to connect the
phosphorylated metabolic enzymes to protein kinases. Because
many protein kinases recognize a similar consensus motif of
amino acid sequences of substrates, some of the relationships
between the metabolic enzymes and protein kinases might not
be accurately predicted and should be experimentally tested
further. Additionally, information regarding biological and cellular
contexts such as colocalization and network could be used for
predicting in vivo kinase-substrates relationships (Joughin
et al., 2012; Linding et al., 2007).We used the BRENDA database
for identifying allosteric regulation. In general, the allosteric regu-
lation has been examined in vitro, and it is difficult to validate theCelallosteric regulation at the cellular level. Here, we propose kinetic
modeling with the variable selection method to eliminate the
nonessential variables and to identify the essential variables for
dynamic signal flow. In addition, because the numbers and qual-
ity of the trans-omic data in this study might not be sufficient, the
parameters in the kinetic model might not be reliable. In the
future, whenmore quantitative high-throughput omic technology
becomes available, this problem will be solved and our method
will become more valid and useful.
Trans-omic analyses of global networks ofmetabolic control in
Escherichia coli (Ishii et al., 2007), Bacillus subtilis (Buescher
et al., 2012), and Saccharomyces cerevisiae (Oliveira et al.,
2012) have been reported. Ishii et al. measured transcripts, pro-
tein abundance, metabolites, and metabolic fluxes of E. coli
under four growth conditions and 24 disruptants; they found
that the metabolite levels remained stable against environmental
perturbations by enzyme-level regulation and against genetic
perturbation by flux rerouting (Ishii et al., 2007). Buescher et al.
measured time courses of transcripts, protein abundance, me-
tabolites, and metabolic fluxes of B. subtilis using two nutrient-
shift experiments and also identified transcriptional regulatory
networks based on chromatin immunoprecipitation (ChIP)-on-
chip (Buescher et al., 2012). They analyzed the mechanism of
adaptation tomalate and glucose across the transcriptome layer
and the metabolome/fluxome layer and showed that the meta-
bolic fluxes of B. subtilis are primarily changed by transcriptional
regulation when the nutrient source is shifted from malate to
glucose, but that posttranscriptional modulation is utilized
when the nutrient shift is from glucose to malate. Oliveira et al.
measured protein phosphorylation and metabolites of S. cerevi-
siae and combined them with protein abundance and flux data
(Oliveira et al., 2012). These authors concluded whether the
phosphorylation of metabolic enzymes work positively or nega-
tively regarding reaction rates of the enzymes based on the cor-
relations of phosphorylation and flux; this has been further
confirmed by measuring the concentration of substrates and
products of the enzymes. Furthermore, recent advances
allow systematic identification of allosteric protein-metabolitel Reports 8, 1171–1183, August 21, 2014 ª2014 The Authors 1179
Figure 6. Analysis of the Dynamic Signal Flow in a Local Trans-Omic Network of Conversion of F6P to F1,6BP Corresponding to Step vii
(A) The local trans-omic network of F1,6BP regulation. White boxes and green boxes indicate metabolites and metabolic enzymes, respectively. Solid arrows
indicate enzymatic reactions. Dashed lines with arrow heads and with flat heads indicate the allosteric regulation of activators and inhibitors, respectively. Black
and gray metabolites are essential and nonessential variables, respectively (see D). The location of the network in central carbon metabolism is indicated by red
(inset). ALDO, aldolase. The other abbreviations for the molecules are shown in Table S5.
(legend continued on next page)
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interactions that control enzyme activity in vivo (Link et al., 2013).
In addition to these trans-omics studies, phosphoproteomic
analysis is extensively used to estimate interaction networks in
insulin signaling (Friedman et al., 2011; Humphrey et al., 2013;
Monetti et al., 2011) and other signaling networks (Jørgensen
et al., 2009; Olsen et al., 2006). We measured time-course
data for protein phosphorylation and metabolites in mammalian
cells in response to insulin and reconstructed static signal flow
from insulin to metabolites through phosphorylation and allo-
steric regulation. We analyzed the dynamic signal flow by kinetic
modeling with variable selection and found that insulin coordi-
nately regulates the dynamic flow in the glycolytic pathway by
insulin-dependent activation of PFKL via phosphorylation and
an increase in F2,6BP, and by the negative-feedback loop via
downstream allosteric regulators.
Insulin reportedly exhibits several temporal patterns, including
additional secretion (observed in response to meals) and basal
secretion (characterized by persistently low circulating insulin
concentrations) (Lindsay et al., 2003; Polonsky et al., 1988).
We have previously shown that insulin selectively changes the
signal flow through signaling pathways depending on the tem-
poral patterns (Kubota et al., 2012). Rapid pulse stimulation of in-
sulin, which resembles additional secretion of insulin in vivo,
selectively regulates GSK3b and p70S6K, whereas slow ramp
stimulation of insulin, which resembles basal secretion of insulin
in vivo, selectively regulates GSK3b and G6Pase. In another
study, we will apply this method using the trans-omic data in
response to pulse and ramp stimulations of insulin and will
examine the selective signal flow by the specific temporal pat-
terns of insulin in a trans-omic network. We will also expand
our analysis of chronic insulin action by measuring the transcrip-
tome, proteome, lipidome, and epigenome, which would reveal
the vital nature of cellular homeostasis.
Because acute cellular functions primarily use protein phos-
phorylation signaling pathways and secondarily use allosteric
regulation to adapt to extracellular stimuli, our method can visu-
alize signal flow from extracellular stimuli through protein phos-
phorylation pathways and an allosteric regulation network. Our
method can be widely applied to identify the signal flow of any
growth factors and the signaling network at thecellular and in vivo
levels. It would be interesting to apply this method to other
growth factors, such as epidermal growth factor and fibroblast
growth factors, and to compare signal flow between different
types of growth factors and receptors. This type of study would
reveal growth factor-specific or receptor type-specific regulation(B) Enzymatic activities of PFKL. WT, wild-type PFKL. A, D, and E indicate the
glutamate, respectively. The means and SDs of three independent points are sho
Kramer test. ****p < 0.0001; ***0.0001 < p < 0.001; n.s., not significant (p > 0.1).
(C) Time course of F1,6BP in the kinetic model. Solid lines indicate the time cours
PFKL at S775 with 1 nM insulin (see Supplemental Experimental Procedures for d
time course of phosphorylation of PFKL at S775 with 0.01, 1, and 100 nM insulin.
the responses to 100, 1, and 0.01 nM insulin, respectively.
(D) The variable selection with 1 nM insulin stimulation. Residual sum of square
Experimental Procedures for details). Red indicates the threshold for the variable
variables. The variable selection with 100 nM insulin stimulation also provides th
(E) The dynamic signal flow in the kinetic model with the five variables. The time co
difference between PFKL and FBPase (Figure S4L).
See also Figure S4.
Celfrom the viewpoint of signal flow in a trans-omic network, which is
characterized by different modes of action at the systems level.
EXPERIMENTAL PROCEDURES
The detailed experimental procedures can be found in Supplemental Experi-
mental Procedures.
Cell Treatments and Comprehensive Measurements
Rat hepatoma FAO cells were stimulated by the indicated doses of insulin and
were used for phosphoproteome and metabolome measurements. The phos-
phoproteome data and metabolome data were processed to reconstruct the
static and dynamic signal flows of insulin by using the following seven steps.
Reconstruction of Static and Dynamic Signal Flow in a Trans-Omic
Network
Step i: S1 / S0 values (see Figure S3 and Supplemental Experimental
Procedures for definition) of each metabolite were calculated to identify
quantitatively changed metabolites that are equivalent to the metabolites
satisfying j S1 / S0 j > 1.
Step ii: responsible metabolic enzymes that produce or consume at least
one quantitatively changedmetabolite are identified using the KEGG data-
base in combination with the calculated S1 / S0 values.
Step iii: significantly phosphorylated responsible metabolic enzymes were
identified using the phosphoproteomic data. A phosphopeptide whose
phosphorylation intensity was greater than a 1.5-fold increase or less
than 0.67-fold decrease at more than one time point was determined as
a quantitatively changed phosphorylation.
Step iv: responsible protein kinases of the significantly phosphorylated
responsible metabolic enzymes were estimated using NetPhorest. The
responsible protein kinase was connected to the insulin-signaling pathway
if it was included in this pathway map.
Step v: the information regarding allosteric effectors acting on the respon-
sible metabolic enzymes was extracted from the BRENDA database.
Step vi: the static signal flow of acute insulin action in a trans-omic network
was reconstructed by integrating the results of steps i through v.
Step vii: dynamic signal flow around PFKL was identified using a kinetic
model.
PFKL Assay
HEK293 cells transfected with the indicated plasmids harboring cDNA of wild-
type and mutants of mouse PFKL were used for PFKL assay to determine the
function of phosphorylation of PFKL at S775. We performed a variable selec-
tion based on the residual sum of squares between the original full model and
reduced models.
ACCESSION NUMBERS
The Gene Expression Omnibus accession number for the microarray data in
this article is GSE58302. The mathematical models have been deposited
in BioModels Database (Li et al., 2010) and assigned the identifiers
MODEL1406130000 and MODEL1406130001.mutants whose Ser 775 residues were substituted by alanine, aspartate, and
wn. *Statistically significant changes between groups determined by a Tukey-
e of F1,6BP based on the experimental time-course data of phosphorylation of
etails). Dashed lines indicate the time course of F1,6BP based on the simulated
The dots indicate experimental data of F1,6BP. Red, green, and blue represent
s (RSS) of the consecutive variable selections are shown (see Supplemental
selection (RSS = 0.001). The five variables above the threshold are essential
e same five variables (Figure S4A).
urse of F1,6BP is an integration of d[F1,6BP] / dt, which is primarily given by the
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